Onco IX - Philochem
Alternative Names: 99mTc-CAIX; PCH-102; PHC-102Latest Information Update: 03 Jan 2024
At a glance
- Originator Philochem
- Class Radiopharmaceutical diagnostics; Small molecules; Technetium compounds
- Mechanism of Action Radionuclide imaging enhancers; Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Renal cell carcinoma
- Discontinued Prostate cancer
Most Recent Events
- 03 Jan 2024 Onco IX is still in Phase I trials for Renal-cell-carcinoma(Diagnosis) in Switzerland (Philochem pipeline, January 2023)
- 28 Dec 2023 No recent reports of development identified for phase-I development in Renal-cell-carcinoma(Diagnosis) in Switzerland (Parenteral)
- 26 Mar 2023 Discontinued - Preclinical for Prostate cancer (Diagnosis) in Switzerland (Parenteral)(Philogen pipeline, March 2023)